ABBVIE INCABBVIE INCABBVIE INC

ABBVIE INC

Sem negociações
Veja nos super gráficos

ABBV títulos

Abaixo está a lista de títulos corporativos ABBVIE INC. Os investidores geralmente optam pelos títulos de uma empresa por sua maior estabilidade em épocas de volatilidade do mercado. Estude preços, rendimentos e outras estatísticas e encontre um investimento confiável.
Símbolo
YTM %
Volume
Preço %
Cupom %
Data de vencimento
Montante em circulação
Valor de face
Valor mín. de denominação
Emissor
AA5QDALLERGAN FNDG 15/25
8,33%099,79%3,80%2025-03-15130,22 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
8,14%50 K74,10%4,75%2045-03-1553,51 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
7,72%24 K76,91%4,63%2042-10-0167,49 M USD1.000,00 USD2.000,00 USDActavis, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
7,69%15 K77,85%4,85%2044-06-1565,23 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
7,11%20 K84,96%4,55%2035-03-15107,65 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
6,46%14,78 M99,87%3,80%2025-03-152,89 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,76%41,72 M84,57%4,25%2049-11-215,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,75%235 K90,14%4,63%2042-10-01389,22 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,74%26 K90,47%3,20%2029-11-2162,52 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5,67%088,21%4,45%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5,61%091,36%4,70%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,56%6,85 M89,69%4,40%2042-11-062,6 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,55%4,94 M93,08%4,88%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,53%145 K92,55%4,75%2045-03-15827,09 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,51%3,57 M88,16%4,05%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,49%573 K100,08%5,50%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,49%500 K94,02%4,85%2044-06-151,01 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,39%40,92 M100,08%5,40%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5,33%32,92 M103,17%5,60%2055-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,28%2,25 M100,62%5,35%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5,22%093,50%4,30%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5,11%095,91%4,50%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5,08%5,54 M96,50%4,55%2035-03-151,68 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4,94%099,72%3,60%2025-05-143,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
4,94%21,01 M101,75%5,20%2035-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4,93%22,7 M100,76%5,05%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,72%27,25 M94,11%3,20%2029-11-215,44 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,65%9,48 M101,41%4,95%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
4,63%23,62 M101,00%4,88%2030-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,57%2,75 M100,79%4,80%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4,47%10,72 M99,29%4,25%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
4,46%20,49 M100,50%4,65%2028-03-151,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,42%098,60%3,20%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4,42%13,63 M97,63%2,95%2026-11-213,99 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4,40%1,01 M100,75%4,80%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
4,25%094,77%2,63%2028-11-1572,11 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
3,87%093,63%2,13%2029-06-0136,46 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
3,86%096,53%2,95%2026-11-219,24 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
3,08%089,80%1,25%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
3,01%0102,15%3,80%2025-03-151,27 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
2,90%0121,31%4,25%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
2,88%0126,76%4,75%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,83%0128,71%4,85%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS212591491ABBVIE 20/29
2,80%097,42%2,13%2029-06-01506,09 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2,75%099,58%2,63%2028-11-15427,79 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2,73%097,94%2,13%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2,65%095,18%0,75%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,35%0123,74%4,55%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
3,80%2025-03-151.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
4,40%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.